Stockscreener 앱 받기
176.98
2.32%
4.02
시장 영업 전:
178.10
1.12
+0.63%
전일 마감가:
$172.96
열려 있는:
$173.455
하루 거래량:
10.62M
Relative Volume:
1.81
시가총액:
$281.28B
수익:
$113.10B
순이익/손실:
$16.33B
주가수익비율:
18.17
EPS:
9.7425
순현금흐름:
$10.35B
1주 성능:
-0.80%
1개월 성능:
+9.05%
6개월 성능:
+33.55%
1년 성능:
+46.87%
1일 변동 폭
$173.46
$177.70
1주일 범위
$172.58
$180.90
52주 변동 폭
$94.33
$181.98
모건 스탠리 Stock (MS) Company Profile
명칭
Morgan Stanley
전화
212-761-4000
주소
1585 BROADWAY, NEW YORK, NY
MS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
176.98 | 274.89B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
893.48 | 262.83B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
98.82 | 172.77B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
121.35 | 105.35B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
362.46 | 28.23B | 14.13B | 1.12B | 45.45M | 14.62 |
모건 스탠리 Stock (MS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-07-09 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-09-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-08-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-17 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-11-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-11-20 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | 다운그레이드 | Odeon | Buy → Hold |
| 2023-10-20 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-07 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | Odeon | Hold → Buy |
| 2023-01-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-10 | 업그레이드 | Odeon | Sell → Hold |
| 2023-01-04 | 다운그레이드 | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | 다운그레이드 | Odeon | Hold → Sell |
| 2022-05-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-28 | 다운그레이드 | Odeon | Buy → Hold |
| 2021-12-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | 재확인 | Jefferies | Buy |
| 2021-09-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-09-28 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-08-13 | 다운그레이드 | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | 재개 | Keefe Bruyette | Outperform |
| 2021-06-09 | 개시 | Jefferies | Buy |
| 2021-04-21 | 업그레이드 | Berenberg | Hold → Buy |
| 2021-03-02 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | 개시 | Daiwa Securities | Neutral |
| 2021-01-04 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-11-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-13 | 재개 | JP Morgan | Overweight |
| 2020-07-08 | 개시 | Seaport Global Securities | Buy |
| 2020-06-24 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2020-06-23 | 재확인 | UBS | Buy |
| 2020-05-21 | 업그레이드 | Odeon | Hold → Buy |
| 2020-04-14 | 업그레이드 | Societe Generale | Sell → Buy |
| 2020-03-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-21 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2020-02-20 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-01-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | 개시 | DA Davidson | Buy |
| 2020-01-06 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-29 | 다운그레이드 | Odeon | Buy → Hold |
| 2019-10-10 | 업그레이드 | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-04-18 | 다운그레이드 | Citigroup | Buy → Neutral |
모두보기
모건 스탠리 주식(MS)의 최신 뉴스
Paychex (NASDAQ:PAYX) Price Target Lowered to $123.00 at Morgan Stanley - MarketBeat
SolarEdge Technologies (SEDG): Reassessing Valuation After Morgan Stanley’s Upgrade and Renewed Analyst Optimism - simplywall.st
Monster Beverage (MNST) Gains Favor with Morgan Stanley's Positi - GuruFocus
Here are the macro surprises that Morgan Stanley says could trip up investors next year - MarketWatch
Morgan Stanley Adjusts Price Target on Monster Beverage to $87 From $81, Maintains Overweight Rating - marketscreener.com
Charles Schwab price target raised to $148 from $139 at Morgan Stanley - TipRanks
Morgan Stanley Adjusts PT on Martin Marietta Materials to $690 From $660, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Paychex to $123 From $133, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Robinhood Markets to $147 From $146, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Raymond James Financial to $187 From $185, Keeps Equalweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Ameriprise Financial to $485 From $484, Maintains Underweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on General Mills to $47 From $48, Maintains Underweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on CME Group to $320 From $314, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Charles Schwab Corp to $148 From $139, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Nasdaq to $111 From $110, Maintains Overweight Rating - marketscreener.com
Morgan Stanley Adjusts PT on Intercontinental Exchange to $174 From $169, Keeps Equalweight Rating - marketscreener.com
2026 Market Outlook Based on Current Valuations - Investing.com
Morgan Stanley $MS Shares Sold by Clarius Group LLC - MarketBeat
Morgan Stanley (MS) Likely to Serve as Lead Underwriter on Blockbuster SpaceX IPO - TipRanks
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley Capital Services discloses Avadel Pharmaceuticals trades - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com India
Morgan Stanley downgrades Titagarh Rail stock on margin concerns - Investing.com
Morgan Stanley Ceases to Be Substantial Holder in Arafura Rare Earths - TipRanks
DraftKings: Morgan Stanley weighs in on prediction markets push - Investing.com
Taking Stock of IDACORP (IDA) After Morgan Stanley’s Upgrade: What the New Growth Story Means for Valuation - simplywall.st
Morgan Stanley Boosts Apple (AAPL) Target, Sees Upside From Pricing Power and AI - Finviz
Morgan Stanley Upgrades L3Harris Technologies, Inc. (LHX) Buoyed by Golden Dome Opportunities - Insider Monkey
Morgan Stanley Cuts Coupang (CPNG) PT to $31 Over Security Risks, Maintains Overweight Rating - Yahoo Finance
Morgan Stanley Slashes PT on Netflix (NFLX) to $120 From $150, Keeps an Overweight Rating - Insider Monkey
Morgan Stanley Maintains An Overweight Rating On NextEra Energy, Inc. (NEE) - Finviz
Morgan Stanley Maintains Underweight Rating On Consolidated Edison, Inc. (ED) - Insider Monkey
Morgan Stanley Lowers Price Objective On Exelon Corporation (EXC) - Insider Monkey
QXO (QXO): Morgan Stanley shares bullish outlook - MSN
QXO (QXO): Morgan Stanley Shares Bullish Outlook - Insider Monkey
Cisco, Arista remain in line for excess returns among networking in 2026: Morgan Stanley - Seeking Alpha
Sarasin & Partners LLP Has $6.90 Million Holdings in Morgan Stanley $MS - MarketBeat
Morgan Stanley $MS Shares Acquired by Flputnam Investment Management Co. - MarketBeat
Does Morgan Stanley’s Expanding ETF And Deal Franchise Reshape The Bull Case For MS? - Yahoo Finance
Morgan Stanley Reveals Its Top Chip Stocks for 2026 - TipRanks
Morgan Stanley questions the future of the low-cost airline model - Investing.com
Morgan Stanley $MS Position Trimmed by Douglas Lane & Associates LLC - MarketBeat
Cinemark Holdings (CNK): Reassessing Valuation After Morgan Stanley’s Downgrade and Shifting Investor Sentiment - Yahoo Finance
Morgan Stanley asks: Is UNH "the CVS of 2026"? - Investing.com
Here is what Morgan Stanley thinks will likely to shape stocks in 2026 - Investing.com
Morgan Stanley maps the retail winners and losers from agentic shoppers - Investing.com
Is Morgan Stanley Still Attractive After Its 41.8% 2025 Surge? - Yahoo Finance
Is Morgan Stanley’s Rally Justified After Wealth Management Pivot and Strong 2025 Share Gains? - simplywall.st
Hershey (HSY): Reassessing Valuation After Morgan Stanley’s Overweight Upgrade and Earnings Growth Outlook - Yahoo Finance
L3Harris (LHX) Valuation After Major Space Contract Win and Morgan Stanley Upgrade - simplywall.st
Astera Labs (ALAB): Assessing Valuation After Morgan Stanley’s AI and Data Center Endorsement - simplywall.st
모건 스탠리 (MS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.96%
자본화:
|
볼륨(24시간):